Global Biosimilar Monoclonal Antibodies Market Growth 2019-2024

Publisher Name :
Date: 22-Oct-2019
No. of pages: 134

According to this study, over the next five years the Biosimilar Monoclonal Antibodies market will register a 28.7% CAGR in terms of revenue, the global market size will reach US$ 9412.4 million by 2024, from US$ 3429.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilar Monoclonal Antibodies business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Monoclonal Antibodies market by product type, application, key manufacturers and key regions and countries.

This study considers the Biosimilar Monoclonal Antibodies value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

- Infliximab

- Rituximab

- Trastuzumab

- Adalimumab

- Other

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

- Oncology

- Autoimmune Disease

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Celltrion

- Pfizer (Hospira)

- Novartis (Sandoz)

- Dr Reddy's

- 3SBIO

- Hisun Pharma

- Celgen Biopharma

- Torrent Pharmaceuticals

- Cadila Healthcare

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Biosimilar Monoclonal Antibodies consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

- To understand the structure of Biosimilar Monoclonal Antibodies market by identifying its various subsegments.

- Focuses on the key global Biosimilar Monoclonal Antibodies manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Biosimilar Monoclonal Antibodies with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Biosimilar Monoclonal Antibodies submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Biosimilar Monoclonal Antibodies Market Growth 2019-2024

Table of Contents

Global Biosimilar Monoclonal Antibodies Market Growth 2019-2024

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Monoclonal Antibodies Consumption 2014-2024
2.1.2 Biosimilar Monoclonal Antibodies Consumption CAGR by Region
2.2 Biosimilar Monoclonal Antibodies Segment by Type
2.2.1 Infliximab
2.2.2 Rituximab
2.2.3 Trastuzumab
2.2.4 Adalimumab
2.2.5 Other
2.3 Biosimilar Monoclonal Antibodies Consumption by Type
2.3.1 Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2014-2019)
2.3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2014-2019)
2.3.3 Global Biosimilar Monoclonal Antibodies Sale Price by Type (2014-2019)
2.4 Biosimilar Monoclonal Antibodies Segment by Application
2.4.1 Oncology
2.4.2 Autoimmune Disease
2.4.3 Other
2.5 Biosimilar Monoclonal Antibodies Consumption by Application
2.5.1 Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
2.5.2 Global Biosimilar Monoclonal Antibodies Value and Market Share by Application (2014-2019)
2.5.3 Global Biosimilar Monoclonal Antibodies Sale Price by Application (2014-2019)

3 Global Biosimilar Monoclonal Antibodies by Manufacturers
3.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers
3.1.1 Global Biosimilar Monoclonal Antibodies Sales by Manufacturers (2017-2019)
3.1.2 Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2019)
3.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturers
3.2.1 Global Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2017-2019)
3.2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Biosimilar Monoclonal Antibodies Sale Price by Manufacturers
3.4 Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Biosimilar Monoclonal Antibodies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Biosimilar Monoclonal Antibodies by Regions
4.1 Biosimilar Monoclonal Antibodies by Regions
4.1.1 Global Biosimilar Monoclonal Antibodies Consumption by Regions
4.1.2 Global Biosimilar Monoclonal Antibodies Value by Regions
4.2 Americas Biosimilar Monoclonal Antibodies Consumption Growth
4.3 APAC Biosimilar Monoclonal Antibodies Consumption Growth
4.4 Europe Biosimilar Monoclonal Antibodies Consumption Growth
4.5 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Growth

5 Americas
5.1 Americas Biosimilar Monoclonal Antibodies Consumption by Countries
5.1.1 Americas Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019)
5.1.2 Americas Biosimilar Monoclonal Antibodies Value by Countries (2014-2019)
5.2 Americas Biosimilar Monoclonal Antibodies Consumption by Type
5.3 Americas Biosimilar Monoclonal Antibodies Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Biosimilar Monoclonal Antibodies Consumption by Countries
6.1.1 APAC Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019)
6.1.2 APAC Biosimilar Monoclonal Antibodies Value by Countries (2014-2019)
6.2 APAC Biosimilar Monoclonal Antibodies Consumption by Type
6.3 APAC Biosimilar Monoclonal Antibodies Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Biosimilar Monoclonal Antibodies by Countries
7.1.1 Europe Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019)
7.1.2 Europe Biosimilar Monoclonal Antibodies Value by Countries (2014-2019)
7.2 Europe Biosimilar Monoclonal Antibodies Consumption by Type
7.3 Europe Biosimilar Monoclonal Antibodies Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Biosimilar Monoclonal Antibodies by Countries
8.1.1 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Biosimilar Monoclonal Antibodies Value by Countries (2014-2019)
8.2 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Type
8.3 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biosimilar Monoclonal Antibodies Distributors
10.3 Biosimilar Monoclonal Antibodies Customer

11 Global Biosimilar Monoclonal Antibodies Market Forecast
11.1 Global Biosimilar Monoclonal Antibodies Consumption Forecast (2019-2024)
11.2 Global Biosimilar Monoclonal Antibodies Forecast by Regions
11.2.1 Global Biosimilar Monoclonal Antibodies Forecast by Regions (2019-2024)
11.2.2 Global Biosimilar Monoclonal Antibodies Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biosimilar Monoclonal Antibodies Forecast by Type
11.8 Global Biosimilar Monoclonal Antibodies Forecast by Application

12 Key Players Analysis
12.1 Celltrion
12.1.1 Company Details
12.1.2 Biosimilar Monoclonal Antibodies Product Offered
12.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Celltrion News
12.2 Pfizer (Hospira)
12.2.1 Company Details
12.2.2 Biosimilar Monoclonal Antibodies Product Offered
12.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Pfizer (Hospira) News
12.3 Novartis (Sandoz)
12.3.1 Company Details
12.3.2 Biosimilar Monoclonal Antibodies Product Offered
12.3.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Novartis (Sandoz) News
12.4 Dr Reddy's
12.4.1 Company Details
12.4.2 Biosimilar Monoclonal Antibodies Product Offered
12.4.3 Dr Reddy's Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Dr Reddy's News
12.5 3SBIO
12.5.1 Company Details
12.5.2 Biosimilar Monoclonal Antibodies Product Offered
12.5.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 3SBIO News
12.6 Hisun Pharma
12.6.1 Company Details
12.6.2 Biosimilar Monoclonal Antibodies Product Offered
12.6.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Hisun Pharma News
12.7 Celgen Biopharma
12.7.1 Company Details
12.7.2 Biosimilar Monoclonal Antibodies Product Offered
12.7.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Celgen Biopharma News
12.8 Torrent Pharmaceuticals
12.8.1 Company Details
12.8.2 Biosimilar Monoclonal Antibodies Product Offered
12.8.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Torrent Pharmaceuticals News
12.9 Cadila Healthcare
12.9.1 Company Details
12.9.2 Biosimilar Monoclonal Antibodies Product Offered
12.9.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Cadila Healthcare News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Biosimilar Monoclonal Antibodies
Table Product Specifications of Biosimilar Monoclonal Antibodies
Figure Biosimilar Monoclonal Antibodies Report Years Considered
Figure Market Research Methodology
Figure Global Biosimilar Monoclonal Antibodies Consumption Growth Rate 2014-2024 (K Units)
Figure Global Biosimilar Monoclonal Antibodies Value Growth Rate 2014-2024 ($ Millions)
Table Biosimilar Monoclonal Antibodies Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of Infliximab
Table Major Players of Infliximab
Figure Product Picture of Rituximab
Table Major Players of Rituximab
Figure Product Picture of Trastuzumab
Table Major Players of Trastuzumab
Figure Product Picture of Adalimumab
Table Major Players of Adalimumab
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2014-2019)
Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2014-2019)
Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2014-2019)
Table Global Biosimilar Monoclonal Antibodies Revenue by Type (2014-2019) ($ million)
Table Global Biosimilar Monoclonal Antibodies Value Market Share by Type (2014-2019) ($ Millions)
Figure Global Biosimilar Monoclonal Antibodies Value Market Share by Type (2014-2019)
Table Global Biosimilar Monoclonal Antibodies Sale Price by Type (2014-2019)
Figure Biosimilar Monoclonal Antibodies Consumed in Oncology
Figure Global Biosimilar Monoclonal Antibodies Market: Oncology (2014-2019) (K Units)
Figure Global Biosimilar Monoclonal Antibodies Market: Oncology (2014-2019) ($ Millions)
Figure Biosimilar Monoclonal Antibodies Consumed in Autoimmune Disease
Figure Global Biosimilar Monoclonal Antibodies Market: Autoimmune Disease (2014-2019) (K Units)
Figure Global Biosimilar Monoclonal Antibodies Market: Autoimmune Disease (2014-2019) ($ Millions)
Figure Biosimilar Monoclonal Antibodies Consumed in Other
Figure Global Biosimilar Monoclonal Antibodies Market: Other (2014-2019) (K Units)
Figure Global Biosimilar Monoclonal Antibodies Market: Other (2014-2019) ($ Millions)
Table Global Consumption Sales by Application (2014-2019)
Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
Table Global Biosimilar Monoclonal Antibodies Value by Application (2014-2019)
Table Global Biosimilar Monoclonal Antibodies Value Market Share by Application (2014-2019)
Figure Global Biosimilar Monoclonal Antibodies Value Market Share by Application (2014-2019)
Table Global Biosimilar Monoclonal Antibodies Sale Price by Application (2014-2019)
Table Global Biosimilar Monoclonal Antibodies Sales by Manufacturers (2017-2019) (K Units)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2019)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers in 2017
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers in 2018
Table Global Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2017-2019) ($ Millions)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturers (2017-2019)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturers in 2017
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturers in 2018
Table Global Biosimilar Monoclonal Antibodies Sale Price by Manufacturers (2017-2019)
Figure Global Biosimilar Monoclonal Antibodies Sale Price by Manufacturers in 2018
Table Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution and Sales Area by Manufacturers
Table Players Biosimilar Monoclonal Antibodies Products Offered
Table Biosimilar Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Biosimilar Monoclonal Antibodies Consumption by Regions 2014-2019 (K Units)
Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Regions 2014-2019
Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Regions 2014-2019
Table Global Biosimilar Monoclonal Antibodies Value by Regions 2014-2019 ($ Millions)
Table Global Biosimilar Monoclonal Antibodies Value Market Share by Regions 2014-2019
Figure Global Biosimilar Monoclonal Antibodies Value Market Share by Regions 2014-2019
Figure Americas Biosimilar Monoclonal Antibodies Consumption 2014-2019 (K Units)
Figure Americas Biosimilar Monoclonal Antibodies Value 2014-2019 ($ Millions)
Figure APAC Biosimilar Monoclonal Antibodies Consumption 2014-2019 (K Units)
Figure APAC Biosimilar Monoclonal Antibodies Value 2014-2019 ($ Millions)
Figure Europe Biosimilar Monoclonal Antibodies Consumption 2014-2019 (K Units)
Figure Europe Biosimilar Monoclonal Antibodies Value 2014-2019 ($ Millions)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Consumption 2014-2019 (K Units)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Value 2014-2019 ($ Millions)
Table Americas Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019) (K Units)
Table Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2014-2019)
Figure Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2018
Table Americas Biosimilar Monoclonal Antibodies Value by Countries (2014-2019) ($ Millions)
Table Americas Biosimilar Monoclonal Antibodies Value Market Share by Countries (2014-2019)
Figure Americas Biosimilar Monoclonal Antibodies Value Market Share by Countries in 2018
Table Americas Biosimilar Monoclonal Antibodies Consumption by Type (2014-2019) (K Units)
Table Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2014-2019)
Figure Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2018
Table Americas Biosimilar Monoclonal Antibodies Consumption by Application (2014-2019) (K Units)
Table Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
Figure Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2018
Figure United States Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure United States Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure Canada Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Canada Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure Mexico Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Mexico Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Table APAC Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019) (K Units)
Table APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2014-2019)
Figure APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2018
Table APAC Biosimilar Monoclonal Antibodies Value by Countries (2014-2019) ($ Millions)
Table APAC Biosimilar Monoclonal Antibodies Value Market Share by Countries (2014-2019)
Figure APAC Biosimilar Monoclonal Antibodies Value Market Share by Countries in 2018
Table APAC Biosimilar Monoclonal Antibodies Consumption by Type (2014-2019) (K Units)
Table APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2014-2019)
Figure APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2018
Table APAC Biosimilar Monoclonal Antibodies Consumption by Application (2014-2019) (K Units)
Table APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
Figure APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2018
Figure China Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure China Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure Japan Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Japan Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure Korea Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Korea Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure India Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure India Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure Australia Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Australia Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Table Europe Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019) (K Units)
Table Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2014-2019)
Figure Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2018
Table Europe Biosimilar Monoclonal Antibodies Value by Countries (2014-2019) ($ Millions)
Table Europe Biosimilar Monoclonal Antibodies Value Market Share by Countries (2014-2019)
Figure Europe Biosimilar Monoclonal Antibodies Value Market Share by Countries in 2018
Table Europe Biosimilar Monoclonal Antibodies Consumption by Type (2014-2019) (K Units)
Table Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2014-2019)
Figure Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2018
Table Europe Biosimilar Monoclonal Antibodies Consumption by Application (2014-2019) (K Units)
Table Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
Figure Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2018
Figure Germany Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Germany Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure France Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure France Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure UK Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure UK Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure Italy Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Italy Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure Russia Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Russia Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure Spain Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Spain Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Table Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Countries (2014-2019) (K Units)
Table Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2014-2019)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2018
Table Middle East & Africa Biosimilar Monoclonal Antibodies Value by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Biosimilar Monoclonal Antibodies Value Market Share by Countries (2014-2019)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Value Market Share by Countries in 2018
Table Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Type (2014-2019) (K Units)
Table Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2014-2019)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2018
Table Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Application (2014-2019) (K Units)
Table Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2018
Figure Egypt Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Egypt Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure South Africa Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure South Africa Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure Israel Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Israel Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure Turkey Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure Turkey Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Figure GCC Countries Biosimilar Monoclonal Antibodies Consumption Growth 2014-2019 (K Units)
Figure GCC Countries Biosimilar Monoclonal Antibodies Value Growth 2014-2019 ($ Millions)
Table Biosimilar Monoclonal Antibodies Distributors List
Table Biosimilar Monoclonal Antibodies Customer List
Figure Global Biosimilar Monoclonal Antibodies Consumption Growth Rate Forecast (2019-2024) (K Units)
Figure Global Biosimilar Monoclonal Antibodies Value Growth Rate Forecast (2019-2024) ($ Millions)
Table Global Biosimilar Monoclonal Antibodies Consumption Forecast by Countries (2019-2024) (K Units)
Table Global Biosimilar Monoclonal Antibodies Consumption Market Forecast by Regions
Table Global Biosimilar Monoclonal Antibodies Value Forecast by Countries (2019-2024) ($ Millions)
Table Global Biosimilar Monoclonal Antibodies Value Market Share Forecast by Regions
Figure Americas Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Americas Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure APAC Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure APAC Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Europe Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Europe Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure United States Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure United States Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Canada Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Canada Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Mexico Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Mexico Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Brazil Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Brazil Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure China Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure China Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Japan Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Japan Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Korea Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Korea Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure India Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure India Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Australia Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Australia Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Germany Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Germany Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure France Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure France Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure UK Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure UK Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Italy Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Italy Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Russia Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Russia Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Spain Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Spain Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Egypt Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Egypt Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure South Africa Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure South Africa Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Israel Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Israel Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure Turkey Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure Turkey Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Figure GCC Countries Biosimilar Monoclonal Antibodies Consumption 2019-2024 (K Units)
Figure GCC Countries Biosimilar Monoclonal Antibodies Value 2019-2024 ($ Millions)
Table Global Biosimilar Monoclonal Antibodies Consumption Forecast by Type (2019-2024) (K Units)
Table Global Biosimilar Monoclonal Antibodies Consumption Market Share Forecast by Type (2019-2024)
Table Global Biosimilar Monoclonal Antibodies Value Forecast by Type (2019-2024) ($ Millions)
Table Global Biosimilar Monoclonal Antibodies Value Market Share Forecast by Type (2019-2024)
Table Global Biosimilar Monoclonal Antibodies Consumption Forecast by Application (2019-2024) (K Units)
Table Global Biosimilar Monoclonal Antibodies Consumption Market Share Forecast by Application (2019-2024)
Table Global Biosimilar Monoclonal Antibodies Value Forecast by Application (2019-2024) ($ Millions)
Table Global Biosimilar Monoclonal Antibodies Value Market Share Forecast by Application (2019-2024)
Table Celltrion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Celltrion Biosimilar Monoclonal Antibodies Market Share (2017-2019)
Table Pfizer (Hospira) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Pfizer (Hospira) Biosimilar Monoclonal Antibodies Market Share (2017-2019)
Table Novartis (Sandoz) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Novartis (Sandoz) Biosimilar Monoclonal Antibodies Market Share (2017-2019)
Table Dr Reddy's Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr Reddy's Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Dr Reddy's Biosimilar Monoclonal Antibodies Market Share (2017-2019)
Table 3SBIO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
Figure 3SBIO Biosimilar Monoclonal Antibodies Market Share (2017-2019)
Table Hisun Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Hisun Pharma Biosimilar Monoclonal Antibodies Market Share (2017-2019)
Table Celgen Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Celgen Biopharma Biosimilar Monoclonal Antibodies Market Share (2017-2019)
Table Torrent Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Market Share (2017-2019)
Table Cadila Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Cadila Healthcare Biosimilar Monoclonal Antibodies Market Share (2017-2019)
  • Global Follow-On-Biologics Market Report 2019, Competitive Landscape, Trends and Opportunities
    Published: 29-Nov-2019        Price: US 2960 Onwards        Pages: 137
    The Follow-On-Biologics market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026. The report mainly studies the size, recent trends and development status of the Follow-On-Biologics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancem......
  • Global Biologics and Biosimilars Market Growth 2019-2024
    Published: 28-Nov-2019        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Biologics and Biosimilars market will register a 4.6% CAGR in terms of revenue, the global market size will reach US$ 256540 million by 2024, from US$ 214000 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biologics and Biosimilars business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Biologics......
  • 2017-2025 World Oncology Biosimilars Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 26-Nov-2019        Price: US 2800 Onwards        Pages: 102
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Oncology Biosimilars , covering Global total and......
  • Global Biologics and Biosimilars Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 22-Nov-2019        Price: US 3300 Onwards        Pages: 166
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • Global Adalimumab Biosimilar Market Professional Survey Report 2019
    Published: 20-Nov-2019        Price: US 3500 Onwards        Pages: 114
    The global Adalimumab Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Adalimumab Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Adalimumab Biosimilar market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent co......
  • Global Biosimilars Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 20-Nov-2019        Price: US 3300 Onwards        Pages: 132
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. The report forecast global Biosimilars market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Biosimilars industry and main market trends. The market research......
  • Global Biologics and Biosimilars Market Study 2016-2026, by Segment (Antibody, Hormone,) , by Market (Tumor, Diabetes,) , by Company (Roche, Amgen,)
    Published: 10-Nov-2019        Price: US 1800 Onwards        Pages: 65
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • Global Biosimilars Market Study 2016-2026, by Segment (Injection, Tablets,) , by Market (Ankylosing Spondylitis, Tumor,) , by Company (Sandoz International, Hospira,)
    Published: 10-Nov-2019        Price: US 1800 Onwards        Pages: 57
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. The global Biosimilars market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Injection - Tablets - Others......
  • Global Biosimilar Drug Market Growth 2019-2024
    Published: 07-Nov-2019        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Biosimilar Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilar Drug business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Drug market by product type......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs